Document is current
Any future updates will be listed below
-
Authors
Rodon, Jordi
O’Neil, Bert
Lim, Christopher
Ammakkanavar, Natraj R.
Torrado, Carlos
Matsuoka, Kazuaki
Hirai, Hiroshi
Miura, Akihiro
Anderson, Bailey
Jin, Leah
Hangai, Nanae
Long, Amanda
Wacheck, Volker
Rosen, Lee
-
Funding
Funding for this research was provided by:
Taiho Oncology
- License Information
-
More Information
Article History
Received: 18 December 2025
Accepted: 3 May 2026
First Online: 18 May 2026
Declarations
:
: The clinical trial was designed and conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines of the International Council for Harmonisation. The protocol and all clinical trial–related materials were approved by the institutional review board at each investigational site.
: All patients provided written informed consent.
: Not applicable.
: J.R., B.O.’N., C.L., N.R.A., and C.T. have no competing interests to declare. K.M., H.H., and A.M. are employees of Taiho Pharmaceutical Co. Ltd. B.A., L.J., N.H., A.L., and V.W. are employees of Taiho Oncology, Inc. L.R. received research funding for UCLA Medical Center from Taiho Oncology, Inc.
